Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Cancer Medicine|November 23, 2022
MET kinase inhibitor reverses resistance to entrectinib induced by hepatocyte growth factor in tumors with NTRK1 or ROS1 rearrangementsYohei Takumi, Sachiko Arai, Chiaki Suzuki, et al.
Thyroid : Official Journal of the American Thyroid Association|November 1, 2016
Assessment of Nutritional Status of Iodine Through Urinary Iodine Screening Among Local Children and Adolescents After the Fukushima Daiichi Nuclear Power Plant AccidentMasaharu Tsubokura, Shuhei Nomura, Hajime Watanobe, et al.
BMC Cancer|February 26, 2020
Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: a case reportYuta Adachi, Naohiro Yanagimura, Chiaki Suzuki, et al.
The Laryngoscope|October 11, 2017
Complications After Endoscopic Laryngopharyngeal SurgeryYo Kishimoto, Tohru Sogami, Ryuji Uozumi, et al.
Internal Medicine (Tokyo, Japan)|September 4, 2024
Effectiveness of Additional Immunosuppressive Drugs for Corticosteroid-refractory Immune Checkpoint Inhibitor-induced Myocarditis: Two Case ReportsHiroyuki Sakaguchi, Shigeki Nanjo, Shigeki Sato, et al.
Internal Medicine (Tokyo, Japan)|June 28, 2021
Mediastinal Malignant Melanoma Markedly Shrinking in Response to NivolumabHiroyuki Sakaguchi, Azusa Tanimoto, Shigeki Sato, et al.
Oxford Medical Case Reports|January 4, 2021
Bronchoesophageal fistula formation after three courses of nivolumab for carcinoma of unknown primary with a subgroup of lung squamous cell carcinomaAkihiro Nishiyama, Hiroyuki Sakaguchi, Naohiro Yanagimura, et al.
Medicine International|June 28, 2024
Clinical outcome of patients with inoperable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus Nab‑paclitaxel as a first‑line therapy: A retrospective analysisHiroyuki Sakaguchi, Azusa Tanimoto, Shigeki Sato, et al.
Cancer Diagnosis & Prognosis|May 9, 2022
Methylation of Tumor Suppressive miRNAs in Plasma from Patients With Pancreaticobiliary DiseasesKoushiro Ohtsubo, Kunio Miyake, Sachiko Arai, et al.
International Cancer Conference Journal|July 23, 2026
A case of ER-positive, HER2-negative metastatic breast cancer with high tumor mutation burden achieving complete response to pembrolizumab monotherapyAkihiro Umejima, Nobuko Kawaguchi-Sakita, Yosuke Yamada, et al.
Pageof 5